Lou Tartaglia
Managing Partner at Cure Ventures
About
Co-founder with over 30 years of scientific and therapeutic product leadership in biotech and investment experience at multiple venture capital firms. Led company formation initiatives at 5AM Ventures, serving as interim CEO of Entrada Therapeutics and Chief Scientific Officer roles at Editas, Rhythm, and Agios. Began career at Millennium Pharmaceuticals as first employee.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Jeffrey M. Jonas
Partner at Cure Ventures